BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15950667)

  • 1. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study.
    Cicinelli E; de Ziegler D; Alfonso R; Nicoletti R; Bellavia M; Colafiglio G
    Fertil Steril; 2005 Jun; 83(6):1859-63. PubMed ID: 15950667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estradiol and oral or vaginal natural progesterone: bleeding patterns.
    Di Carlo C; Tommaselli GA; Gargano V; Savoia F; Bifulco G; Nappi C
    Climacteric; 2010 Oct; 13(5):442-6. PubMed ID: 20575654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding profiles and effects on the endometrium for women using a novel combination of transdermal oestradiol and natural progesterone cream as part of a continuous combined hormone replacement regime.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    BJOG; 2005 Oct; 112(10):1402-6. PubMed ID: 16167944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol.
    Fernández-Murga L; Hermenegildo C; Tarín JJ; García-Pérez MÁ; Cano A
    Climacteric; 2012 Oct; 15(5):455-9. PubMed ID: 22321028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women.
    Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB
    Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and safety of 28-day transdermal estrogen regimen during vaginal hysterectomy (a controlled trial).
    Vesna A; Neli B
    Maturitas; 2006 Feb; 53(3):282-98. PubMed ID: 16011883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice-weekly transdermal estradiol and vaginal progesterone as continuous combined hormone replacement therapy in postmenopausal women: a 1-year prospective study.
    Cicinelli E; de Ziegler D; Galantino P; Pinto V; Barba B; Morgese S; Schonauer S
    Am J Obstet Gynecol; 2002 Sep; 187(3):556-60. PubMed ID: 12237627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.
    Checa MA; Garrido A; Prat M; Conangla M; Rueda C; Carreras R
    Maturitas; 2005 Sep; 52(1):70-7. PubMed ID: 16143228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone].
    Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL
    Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.
    Clisham PR; Cedars MI; Greendale G; Fu YS; Gambone J; Judd HL
    Obstet Gynecol; 1992 Feb; 79(2):196-201. PubMed ID: 1731285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
    Sun A; Lin S; Wei Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.